Targeting liposomes to endothelial cells in inflammatory diseases

Liposome Technology: Interactions of Liposomes with the Biological Milieu

Volumn , Issue , 2006, Pages 127-150

  Kamps, Jan A A M ^a   Molema, Grietje ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953289569     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (116)

1. Galley HF, Webster NR. Br J Anaesth 2004; 93(1):105-113.
2. Spanjer HH, van Galen M, Roerdink FH, Regts J, Scherphof GL. Biochim Biophys Acta 1986; 863(2):224-230.
3. The Endothelial Cell in Health and Disease. Stuttgart: Schattauer Verlagsgesellschaft, 1995.
4. Ball HJ, McParland B, Driussi C, Hunt NH. Brain Res Brain Res Protoc 2002; 9(3):206-213.
5. Hellstrom M, Gerhardt H, Kalen M, et al. J Cell Biol 2001;153(3):543-553.
6. Griffioen AW, Molema G. Pharmacol Rev 2000; 52(2):237-268.
7. Kuldo JM, Ogawara KI, Werner N, et al. Curr Vasc Pharmacol 2005; 3(1):11-39.
8. Karin M, Yamamoto Y, Wang QM. Nat Rev Drug Discov 2004; 3(1):17-26.
9. English JM, Cobb MH. Trends Pharmacol Sci 2002; 23(1):40-45.
10. Pober JS. Arthritis Res 2002; 4(suppl 3):S109-S116.
11. Harlan JM, Winn RK. Crit Care Med 2002; 30(suppl 5):S214-S219.
12. Madge LA, Pober JS. Exp Mol Pathol 2001; 70(3):317-325.
13. Lim YC, Garcia-Cardena G, Allport JR, et al. Am J Pathol 2003; 162(5) 1591-1601.
14. Von Andrian UH, Mackay CR. N Engl J Med 2000; 343(14):1020-1034.
15. Itoh T, Arai KI. Mechanisms of signal transduction. In: Jacques T, ed. The Cytokine Network and Immune Function. Oxford: Oxford University Press, 1999:169-190.
16. O’Neill LA, Dinarello CA. Immunol Today 2000; 21(5):206-209.
17. Viemann D, Goebeler M, Schmid S, et al. Blood 2004; 103(9):3365-3373.
18. Zhao B, Stavchansky SA, Bowden RA, Bowman PD. Am J Physiol Cell Physiol 2003; 284(6):C1577-C1583.
19. Raab M, Daxecker H, Markovic S, Karimi A, Griesmacher A, Mueller MM. Clin Chim Acta 2002; 321(1-2):11-16.
20. Kumar S, Boehm J, Lee JC. Nat Rev Drug Discov 2003; 2(9):717-726.
21. Salven P, Hattori K, Heissig B, Rafii S. FASEB J 2002; 16(11):1471-1473.
22. Schett G, Tohidast-Akrad M, Smolen JS, et al. Arthritis Rheum 2000; 43(11):2501-2512.
23. Marok R, Winyard PG, Coumbe A, et al. Arthritis Rheum 1996; 39(4):583-591.
24. Stambe C, Nikolic-Paterson DJ, Hill PA, Dowling J, Atkins RC. J Am Soc Nephrol 2004; 15(2):326-336.
25. Thiele K, Bierhaus A, Autschbach F, et al. Gut 1999; 45(5), 693-704.
26. Braet F, Wisse E. Comp Hepatol 2002; 1(1):1.
27. Beljaars L, Melgert BN, Meijer DKF, Molema G, Poelstra K. Neoglyco- and neopeptide albumins for cell-specific delivery of drugs to chronically diseased livers. In: Schreier H, ed. Drug Targeting Technology: A Critical Analysis of Physical, Chemical, and Biological Methods. New York: Marcel Dekker, Inc, 2001:189-240.
28. Malerod L, Juvet K, Gjoen T, Berg T. Cell Tissue Res 2002; 307(2):173-180.
29. Wisse E, Braet F, Luo D, et al. Toxicol Pathol 1996; 24(1):100-111.
30. Lalor PF, Adams DH. Mol Pathol 1999; 52(4):214-219.
31. Paleolog EM. Arthritis Res 2002; 4(suppl 3):S81-S90.
32. Fearon U, Griosios K, Fraser A, et al. J Rheumatol 2003; 30(2):260-268.
33. Canete JD, Pablos JL, Sanmarti R, et al. Arthritis Rheum 2004; 50(5):1636-1641.
34. Ferrara N, Gerber HP, LeCouter J. Nat Med 2003; 9(6):669-676.
35. Weis S, Shintani S, Weber A, et al. J Clin Invest 2004; 113(6):885-894.
36. Ramsauer M, D’Amore PA. J Clin Invest 2002; 110(11):1615-1617.
37. Silletti S, Kessler T, Goldberg J, Boger DL, Cheresh DA. Proc Natl Acad Sci USA 2001; 98(1):119-124.
38. Jain RK. Nat Med 2003; 9(6):685-693.
39. Fabian MA, Biggs WH III, Treiber DK, et al. Nat Biotechnol 2005; 23(3):329-336.
40. Dykxhoorn DM, Novina CD, Sharp PA. Nat Rev Mol Cell Biol 2003; 4(6):457-467.
41. Rijcken E, Krieglstein CF, Anthoni C, et al. Gut 2002:51(4):529-535.
42. Basu P. Nat Med 2003; 9(9):1100-1101.
43. Chen LW, Egan L, Li ZW, Greten FR, Kagnoff MF, Karin M. Nat Med 2003; 9(5):575-581.
44. Blink Bvan den, Juffermans NP, ten Hove T, et al. J Immunol 2001; 166(1):582-587.
45. Scherphof GL, Kamps JA. Prog Lipid Res 2001; 40(3):149-166.
46. Kamps JA, Morselt HW, Scherphof GL. Biochem Biophys Res Commun 1999; 256(1):57-62.
47. Rothkopf C, Fahr A, Fricker G, Scherphof GL, Kamps JAAM. Biochim Biophys Acta-Biomembr 2005; 1668(1):10-16.
48. Koning GA, Schiffelers RM, Storm G. Endothelium 2002; 9(3):161-171.
49. Spragg DD, Alford DR, Greferath R, et al. Proc Natl Acad Sci USA 1997; 94(16):8795-8800.
50. Everts M, Asgeirsdottir SA, Kok RJ, et al. Inflamm Res 2003; 52(12):512-518.
51. Ehrhardt C, Kneuer C, Bakowsky U. Adv Drug Del Rev 2004; 56(4):527-549.
52. Stahn R, Grittner C, Zeisig R, Karsten, U, Felix SB, Wenzel K. Cell Mol Life Sci 2001; 58(1):141-147.
53. Kessner S, Krause A, Rothe U, Bendas G. Biochim Biophys Acta-Biomembr 2001; 1514(2):177-190.
54. Everts M, Koning GA, Kok RJ, et al. Pharm Res 2003; 20(1):64-72.
55. Chiu GN, Bally MB, Mayer LD. Biochim Biophys Acta 2003; 1613(1-2):115-121.
56. Bloemen PG, Henricks PA, van Bloois L, et al. FEBS Lett 1995; 357(2):140-144.
57. Mastrobattista E, Storm G, van Bloois L, et al. Biochim Biophys Acta 1999; 1419(2):353-363.
58. Muro S, Wiewrodt R, Thomas A, et al. J Cell Sci 2003; 116(Pt 8):1599-1609.
59. Schaft DWJ van der, Ramakrishnan S, Molema G, Griffioen AW. Tumor vasculature targeting. In: Molema G, Meijer DKF, eds. Drug Targeting-Organ-Specific Strategies. Weinheim, New York: Wiley-VCH, 2001:233-254.
60. Schraa AJ, Everts M, Kok RJ, Asgeirsdottir SA, Molema G. Biotechnol Ann Rev 2002; 8:133-165.
61. Janssen AP, Schiffelers RM, ten Hagen TL, et al. Int J Pharm 2003; 254(1):55-58.
62. Dubey PK, Mishra V, Jain S, Mahor S, Vyas SP. J Drug Target 2004; 12(5):257-264.
63. Schiffelers RM, Koning GA, ten Hagen TL, et al. J Control Release 2003; 91(1-2):115-122.
64. Pastorino F, Brignole C, Marimpietri D, et al. Cancer Res 2003; 63(21):7400-7409.
65. Kondo M, Asai T, Katanasaka Y, et al. Int J Cancer 2004; 108(2):301-306.
66. Benzinger P, Martiny-Baron G, Reusch P, et al. Biochim Biophys Acta-Biomembr 2000; 1466(1-2):71-78.
67. Volkel T, Holig P, Merdan T, Muller R, Kontermann RE. Biochim Biophys Acta 2004; 1663(1-2):158-166.
68. Thurston G, McLean JW, Rizen M, et al. J Clin Invest 1998; 101(7):1401-1413.
69. Dass CR. J Mol Med 2004; 82(9):579-591.
70. Kamps JA, Morselt HW, Swart PJ, Meijer DK, Scherphof GL. Proc Natl Acad Sci USA 1997; 94(21):11681-11685.
71. Bartsch M, Weeke-Klimp AH, Meijer DK, Scherphof GL, Kamps JA. Pharm Res 2002; 19(5):676-680.
72. Bartsch M, Weeke-Klimp AH, Hoenselaar EP, et al. J Drug Target 2004; 12 (9-10):613-621.
73. Bartsch M, Weeke-Klimp AH, Morselt HW, et al. Mol Pharmacol 2005; 67(3):883-890.
74. Semple SC, Klimuk SK, Harasym TO, et al. Biochim Biophys Acta 2001; 1510(1-2):152-166.
75. Stuart DD, Allen TM. Biochim Biophys Acta 2000; 1463(2):219-229.
76. Stuart DD, Semple SC, Allen TM. Methods Enzymol 2004; 387:171-188.
77. Pardridge WM. Mol Interv 2003; 3(2):90-105, 51.
78. Cornford EM, Cornford ME. Lancet Neurol 2002; 1(5):306-315.
79. Begley DJ. Pharmacol Ther 2004; 104(1):29-45.
80. Torchilin VP, Weissig V, Matin FJ, Heath TD, New RRC. Surface modification of liposomes. In: Torchilin VP, Weissig V, eds. Liposomes a Practical Approach. 2nd ed. Oxford: Oxford University Press, 2003:193-229.
81. Hermanson GT. Bioconjugate Techniques. San Diego: Academic Press Inc., 1996.
82. Shimada K, Kamps JA, Regts J, et al. Biochim Biophys Acta 1997; 1326(2):329-341.
83. Derksen J, Scherphof G. Biochim Biophys Acta-Biomembr 1985; 814(1):151-155.
84. Kamps JA, Swart PJ, Morselt HW, et al. Biochim Biophys Acta 1996; 1278(2):183-190.
85. Bartsch M, Weeke-Klimp A, Morselt HW, et al. Mol Pharmacol 2004.
86. Bendas G, Krause A, Bakowsky U, Vogel J, Rothe U. Int J Pharm 1999; 181(1):79-93.
87. Bendas G, Rothe U, Scherphof GL, Kamps JA. Biophys Acta 2003; 1609(1):63-70.
88. Hansen CB, Kao GY, Moase EH, Zalipsky S, Allen TM. Biochim Biophys Acta 1995; 1239(2):133-144.
89. Koning GA, Morselt HW, Gorter A, et al. Pharm Res 2003; 20(8):1249-1257.
90. Kamps JA, Koning GA, Velinova MJ, et al. J. Drug Target 2000; 8(4):235-245.
91. Düzgünes N, Bagatolli LA, Meers P, Oh YK, Straubinger RM. Fluorescence methods in liposome research. In: Torchilin VP, Weissig V, eds. Lipososmes a Practical Approach. 2nd ed. Oxford: Oxford University press, 2003:105-147.
92. Yan X, Poelstra K, Scherphof GL, Kamps JA. Biochem Biophys Res Commun 2004; 325(3):908-914.
93. Cerletti A, Drewe J, Fricker G, Eberle AN, Huwyler J. J Drug Target 2000; 8(6):435-446.
94. Daleke DL, Hong K, Papahadjopoulos D. Biochim Biophys Acta 1990; 1024(2):352-366.
95. Papadimitriou E, Antimisiaris SG. J Drug Target 2000; 8(5):335-351.
96. Koning GA, Morselt HW, Velinova MJ, et al. Biochim Biophys Acta 1999; 1420(1-2):153-167.
97. Ellens H, Morselt HW, Dontje BH, Kalicharan D, Hulstaert CE, Scherphof GL. Cancer Res 1983; 43(6):2927-2934.
98. Hong K, Friend DS, Glabe CG, Papahadjopoulos D. Biochim Biophys Acta 1983; 732(1):320-323.
99. Huang SK, Hong K, Lee KD, Papahadjopoulos D, Friend DS. Biochim Biophys Acta 1991; 1069(1):117-121.
100. Bouis D, Hospers G, Meijer C, Molema G, Mulder N. Angiogenesis 2001; 4(91):102.
101. Casteleijn E, Van Rooij HC, Van Berkel TJ, Koster JF. FEBS Lett 1986; 201(2):193-197.
102. Kamps JAAM, Scherphof GL. Liposomes in biological systems. In: Torchilin VP, Weissig V, eds. Liposomes a Practical Approach. 2nd ed. Oxford: Oxford University Press, 2003:267-288.
103. Mulder AB, Blom NR, Smit JW, et al. Thromb Res 1995; 80(5):399-411.
104. Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R. Proc Natl Acad Sci USA 1979; 76(11):5674-5678.
105. Braet F, De Zanger R, Sasaoki T, et al. Lab Invest 1994; 70(6):944-952.
106. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. J Biol Chem 1951; 193:265-275.
107. Asgeirsdottir SA, Kok RJ, Everts M, Meijer DKF, Molema G. Biochem Pharmacol 2003; 65:1729-1739.
108. Ohura N, Yamamoto K, Ichioka S, et al. J Atheroscler Thromb 2003; 10(5):304-313.
109. Brooks AR, Lelkes PI, Rubanyi GM. Endothelium 2004; 11(1):45-57.
110. Wasserman SM, Topper JN. Vasc Med 2004; 9(1):35-45.
111. Borza DB, Hudson BG. Kidney Int 2002; 61:1905-1906.
112. Sun Y, Chen HM, Subudhi SK, et al. Nat Med 2002; 8(12):1405-1413.
113. Veihelmann A, Harris AG, Krombach F, Schutze E, Refior HJ, Messmer K. Microcirculation 1999; 6(4):281-290.
114. Farkas S, Herfarth H, Rossle M, et al. Clin Exp Immunol 2001; 126(2):250-258.
115. Asgeirsdottir SA, Werner N, Harms G, Van Den Berg A, Molema G. Ann NY Acad Sci 2002; 973:586-589.
116. Diks SH, Kok K, O’Toole T, et al. J Biol Chem 2004; 279(47):49,206-49,213.